Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Plus Therapeutics Inc PSTV

Healthcare Biotechnology
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The Company is developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers. The Company combines image-guided local beta radiation and targeted drug delivery approaches. The Company is advancing a pipeline of product candidates with lead programs in recurrent glioblastoma... see more

Recent & Breaking News (NDAQ:PSTV)

Cytori to Present at the Jefferies 2014 Global Healthcare Conference on June 4

Business Wire June 3, 2014

Cytori Therapeutics to Raise $10 Million in Registered Direct Offering

Business Wire May 30, 2014

Cytori Reports First Quarter 2014 Business and Financial Results

Business Wire May 12, 2014

Cytori to Webcast First Quarter Financial Results on May 12

Business Wire May 1, 2014

Long-Term Outcomes from Cytori Cell Therapy Trial for Heart Failure Published in American Heart Journal

Business Wire April 14, 2014

Cytori Announces Senior Management Changes

Business Wire April 2, 2014

Independent Sports Medicine Study Using Cytori Cell Therapy to Treat ACL Injury Underway in Spain

Business Wire March 24, 2014

Cytori Therapeutics to Present at Regen Med Investor Day March 26 in New York

Business Wire March 20, 2014

Cytori Reports Fourth Quarter and Full Year 2013 Business and Financial Results

Business Wire March 11, 2014

Cytori Therapeutics to Present at the 26th Annual Roth Conference on March 12

Business Wire March 6, 2014

Cytori to Webcast Fourth Quarter and Year End Financial Results on March 11

Business Wire March 4, 2014

Japan's Bold Initiative in Regenerative Medicine and Who the Big Winners Might Be

Accesswire March 3, 2014

Companies Aligned to Capitalize on New Japanese Regenerative Medicine Initiatives

Accesswire January 13, 2014

Cytori to Initiate U.S. Clinical Trial of Adipose-Derived Regenerative Cells in Hamstring Injuries

Business Wire January 13, 2014

Cytori Announces Presentation at Biotech Showcase(TM) on January 13

Business Wire January 7, 2014

Cytori Therapeutics to Present at the LD Micro Conference on December 5

Business Wire December 3, 2013

Cytori Comments on New Legislation for Regenerative Medicine in Japan

Business Wire November 21, 2013

InvestorsGuru.com 44 Filtered Mid-Day Market Movers Recap

Investors Guru November 10, 2013

Cytori Receives $12 Million for the First Installment from the Lorem Vascular Partnership Equity Agreement

Business Wire November 7, 2013

The Global Revolution in Biotechnology and the Impact of Regenerative Medicine

Accesswire November 7, 2013